Outset Medical(OM)
Focus: Outset Medical is a public medical device company focused on hemodialysis systems for end-stage renal disease (ESRD), anchored by its Tablo platform. The company operates in a specialized nephrology market with ~$130M in annual revenue.
Profile data last refreshed 10m ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
27+3 this month
Stable — net +3 jobs in 30d
12 added, 9 removed. Backfill posture.
Should You Work at Outset Medical?
AI assessmentBest for device-focused or commercial professionals willing to accept higher financial risk for a growth-stage public company in a defensible niche market.
Why Work Here
- Focused portfolio in a large, stable nephrology market with 44% R&D intensity and growing revenue ($130M FY2025, +13% YoY).
- Heavy commercial hiring (9 of 24 active roles) signals market expansion and revenue growth phase for sales-oriented professionals.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$130M
Pipeline & Clinical Trials
Intermittent Renal Replacement Therapy using the Tablo Hemodialysis System
End Stage Kidney DiseaseClinical Trials (1)
NCT04912024Comparative Outcome Measures of Patients Receiving Acute Renal ThErapy Study
N/AHelp build intelligence for Outset Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.